Delivery Order SPE2DE21D7009-SPE2D626F45P7
- Not listed
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $31,798.00 on November 28, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has an ultimate completion date of December 5, 2025 and will be performed in Valencia, California. The award was issued by the Medical Supply Chain, a Defense-related procurement entity within the federal government, with no small...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $1,867.00 on December 15, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment authority has an ultimate completion date of February 6, 2026, and will be performed in Valencia, California. The award was made without a set-aside designation by the Medical Supply Chain, a defense-related procurement entity within...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $36,654.68 on December 15, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has an ultimate completion date of December 29, 2025 and will be performed in Valencia, California. The award is issued under a larger indefinite delivery contract (SPE2DE) with the Defense Logistics Agency Troop Support Medical...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a $1,867.00 fixed-price delivery order with economic price adjustment on November 28, 2025, for pain management medical devices and services. The contract, identified as PAIN MANAGEMENT (4570238376), is set to be completed by December 5, 2025, with performance occurring in Valencia, California. This delivery order was funded by the Medical Supply Chain, a defense-related procurement entity, and represents...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a delivery order valued at $36,589.22 on September 9, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has a completion date of September 19, 2025, and is being performed in Valencia, California. The award carries no set-aside designation, indicating open competition in the federal marketplace. The contract is funded through the Medical...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a delivery order valued at $41,430.34 for pain management medical devices and services. This fixed-price contract with economic price adjustment was awarded on September 9, 2025, with an ultimate completion date of September 19, 2025, and will be performed in Valencia, California. The award carries no set-aside designation, allowing the company to compete openly in the federal marketplace....
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a delivery order valued at $1,838.13 for pain management medical devices under a fixed-price contract with economic price adjustment provisions. The award, issued on November 28, 2025, with an ultimate completion date of December 17, 2025, is funded by the Defense Logistics Agency's Medical Supply Chain division, a defense-related procurement entity supporting the Department of Defense. The...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, received a delivery order valued at $2,683.75 for pain management medical devices on November 28, 2025, with an ultimate completion date of December 5, 2025. The contract employs fixed-price pricing with economic price adjustment and is issued without a small business set-aside. The work will be performed in Valencia, California, under the Defense Logistics Agency's Medical Supply Chain procurement entity....
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a $26,980 delivery order on November 28, 2025, for pain management medical devices and services. The contract, which carries a fixed-price structure with economic price adjustment provisions, is scheduled for completion by December 5, 2025, and will be performed in Valencia, California. This delivery order was issued without a set-aside designation and is funded through the Defense Department's...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a $41,406.68 fixed-price delivery order with economic price adjustment for pain management medical devices and services. The award, issued on September 9, 2025, with an ultimate completion date of September 16, 2025, carries no set-aside designation and will be performed in Valencia, California. This delivery order is issued under Boston Scientific Neuromodulation's larger indefinite...
- SPE2DE21D7009Indefinite Delivery Contract
- SPE2DE21D7009-SPE2D626F45P7Delivery Order
Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $31,877.20 on December 15, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has a completion date of December 29, 2025, and will be performed in Valencia, California. The award carries no small business set-aside designation and is funded by the Medical Supply Chain, a defense-related procurement entity within the Department of Defense. This delivery order is issued under Boston Scientific Neuromodulation's larger indefinite delivery contract (SPE2DE) with the Defense Logistics Agency Troop Support Medical branch, valued at approximately $83.1 million through August 2026, which enables the company to provide comprehensive neuromodulation solutions to military treatment facilities and Veterans Affairs medical centers nationwide. Boston Scientific Neuromodulation specializes in non-opioid pain management technologies, including spinal cord stimulation systems such as the RestoreSensor and Spectra WaveWriter platforms, implantable pain pumps, radiofrequency ablation devices, and associated accessories and technical support. The company has consistently delivered these advanced neuromodulation therapies to federal healthcare agencies, supporting service members and veterans managing chronic pain from traumatic injuries. This delivery order represents a continuation of Boston Scientific's established role as a critical supplier of specialized pain management technologies to the Defense Logistics Agency and broader federal healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.9k | 12/14/25 |